EU Commission wants to exclude devices from SRM (specified risk material) ban
This article was originally published in Clinica
Executive Summary
The European Commission is proposing that medical devices remain excluded from the forthcoming Commission Decision that will ban the use of specified risk materials (SRMs) from animals. It is arguing that devices should not be included on the grounds that risk is already minimised by sector-specific requirements. The Commission also wishes to ensure that they are excluded from coverage under the European Regulation on transmissible spongiform encephalopathies (TSEs), currently being developed.
You may also be interested in...
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.